Human Tissue Kallikreins in Polymorphous Adenocarcinoma: A Polymerase Chain Reaction and Immunohistochemical Study.
Adenocarcinoma
Immunohistochemistry
Reverse transcriptase polymerase chain reaction
Salivary gland neoplasms
Tissue kallikreins
Journal
Head and neck pathology
ISSN: 1936-0568
Titre abrégé: Head Neck Pathol
Pays: United States
ID NLM: 101304010
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
25
05
2020
accepted:
20
06
2020
pubmed:
28
6
2020
medline:
12
11
2021
entrez:
28
6
2020
Statut:
ppublish
Résumé
Polymorphous adenocarcinoma (PAC) is the second most common malignant salivary gland tumour of minor salivary glands. Human tissue kallikreins (KLKs) are a family of highly conserved serine proteases expressed by various tissues and organs. The literature demonstrates a link between KLKs and salivary gland neoplasms. The purpose of this study was to determine levels of KLK mRNA in tissue samples of PAC and to determine if KLK expression is limited to tumour cells. Nineteen cases of PAC were reviewed (1987-2013). The diagnosis was confirmed, demographic data was collected, and formalin fixed paraffin-embedded PAC and normal salivary gland tissue samples were obtained. RNA isolation was achieved, followed by conversion to complementary DNA via reverse transcription. Using PCR, the quantitative level of expression of KLKs1-15 was recorded. Samples exhibiting high and low KLK expression were selected for immunohistochemistry staining. Results revealed a statistically significant increase in mean KLK mRNA expression for KLK1, KLK4, KLK10, KLK12 and KLK15 in PAC tissue samples, compared with normal salivary gland tissue (Mann-Whitney U test, p < 0.05). Immunohistochemistry results demonstrated that KLKs were present in tumor cells. Notably, all samples demonstrating relatively higher KLK mRNA expression showed equivalent or increased staining scores relative to the low KLK mRNA expression samples. In conclusion, there appears to be aberrant kallikrein expression in polymorphous adenocarcinoma, suggesting the possibility of a kallikrein cascade influence on tumor development and progression.
Identifiants
pubmed: 32592124
doi: 10.1007/s12105-020-01196-2
pii: 10.1007/s12105-020-01196-2
pmc: PMC8010004
doi:
Substances chimiques
Biomarkers, Tumor
0
Tissue Kallikreins
EC 3.4.21.35
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
169-178Références
Clin Chem. 2008 Oct;54(10):1600-7
pubmed: 18687738
Clin Chem Lab Med. 2012 Nov;50(11):1877-91
pubmed: 23093268
PLoS One. 2010 Nov 01;5(11):e13781
pubmed: 21072173
Head Neck Pathol. 2020 Sep;14(3):577-587
pubmed: 31515705
Biol Chem. 2010 Jan;391(1):85-95
pubmed: 19919178
Head Neck Pathol. 2015 Mar;9(1):79-84
pubmed: 24969705
Head Neck Pathol. 2015 Jun;9(2):244-52
pubmed: 25322702
J Biol Chem. 2009 Nov 27;284(48):32989-94
pubmed: 19819870
Int J Oncol. 2012 Jan;40(1):80-4
pubmed: 21901247
Int J Biol Markers. 2012 Dec 27;27(4):e381-8
pubmed: 23250777
Minerva Endocrinol. 2002 Sep;27(3):157-66
pubmed: 12091791
Cancer Lett. 2005 Jun 16;224(1):1-22
pubmed: 15911097
Int J Biol Markers. 2010 Jan-Mar;25(1):32-7
pubmed: 20155713
Head Neck Pathol. 2019 Sep;13(3):286-297
pubmed: 30120721
Cancer Res. 2003 Jul 15;63(14):3958-65
pubmed: 12873991
Genes Chromosomes Cancer. 2014 Oct;53(10):845-56
pubmed: 24942367
Int J Biol Markers. 2006 Apr-Jun;21(2):106-10
pubmed: 16847813
Curr Opin HIV AIDS. 2010 Nov;5(6):463-6
pubmed: 20978388
Cancer Res. 2003 Dec 15;63(24):9032-41
pubmed: 14695222
Head Neck Pathol. 2008 Sep;2(3):169-74
pubmed: 20614312
J Clin Oncol. 2003 Aug 15;21(16):3119-26
pubmed: 12915603
Tumour Biol. 2002 May-Jun;23(3):185-92
pubmed: 12218299